Developments NIH awards grant to Marker Therapeutics through SBIR program Marker Therapeutics (NASDAQ:MRKR) has announced that it has been awarded a $2 million grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program to support the clinical... August 12, 2024